✦ LIBER ✦

Leveraging Primary Care in the Fight Against Lung Cancer

✍ Scribed by Jason L. Sanders; Yolonda L. Colson

Book ID: 107413162
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 134 KB
Volume: 23
Category: Article
ISSN: 0884-8734
DOI: 10.1007/s11606-007-0493-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Light-activated antibodies in the fight

Light-activated antibodies in the fight against primary and metastatic cancer

✍ Stephen Thompson; Alexander C. Self; Colin H. Self 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 492 KB

Salmonella—allies in the fight against c

Salmonella—allies in the fight against cancer

✍ Sara Leschner; Siegfried Weiss 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 440 KB

Preserving Primary Care: the Front Line

Preserving Primary Care: the Front Line in the War Against Cancer

✍ Dr. Richard C. Wender 📂 Article 📅 2007 🏛 American Cancer Society 🌐 English ⚖ 41 KB

Early lung cancer detection: the role of

Early lung cancer detection: the role of primary care

✍ Weller, David 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Applications of telomerase research in t

Applications of telomerase research in the fight against cancer

✍ Katherine E McKenzie; Christopher B Umbricht; Saraswati Sukumar 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 670 KB

ChemInform Abstract: New Weapons in the

ChemInform Abstract: New Weapons in the Fight Against Cancer.

✍ I. OJIMA; P.-Y. BOUNAUD; R. J. BERNACKI 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 28 KB

New Weapons in the Fight Against Cancer. -Taxane derivatives (I) and (II) exhibit high multidrug resistance reversal activity against drug-resistant breast cancer cells when coadministered with anticancer drugs such as paclitaxel and doxorubicin. Their negligible cytotoxicity makes them attractive c